References
- Kirchengast S., Hartmann B. The impact of body build on the length of the reproductive span in healthy women. Homo 1995; 46: 125–40
- American Society of Plastic and Reconstructive Surgeons. Statistics. Arlington Heights. ASPRS. 1992; 111
- LeRoy J., Given KS. Wound infection in breast augmentation: the role of prophylactic perioperative antibiotics. Aesthet Plast Surg 1991; 15: 303–5
- Kessler DA. The basis of the FDA's decision on breast implants. N Engl J Med 1992; 326: 1713–15
- Kaiser R., Leidenberger F. Hormonbehandlung in der gynäkologischen Praxis. Georg Thieme Verlag, Stuttgart, New York 1991; 138–9
- Lauritzen C. Hormonkur kann hypoplastischer Mamma aufhelfen. Selecta 1980; 43: 3798–801
- Schubö W., Uehlinger G. SPSSx-Programmversion 2.2. Gustav Fischer Verlag, Stuttgart 1986; 13–25
- Young VL, Nemecek JR, Nenecek DA. The efficacy of breast augmentation: breast size increase, patient satisfaction, and psychological effects. Plast Reconstr Surg 1994; 94: 958–69
- Widdice L. The effects of breast reduction and breast augmentation surgery on lactation: an annotated bibliography. J Hum Lact 1993; 9: 161–7
- Bryant H., Brasher PM, van de Sande JH, et al. Review of methods in breast augmentation: a risk factor for breast cancer?. N Engl J Med 1994; 330: 293
- Birdsell DC, Jenkins H., Berkel H. Breast cancer diagnosis and survival in women with and without breast implants. Plast Reconstr Surg 1993; 92: 795–800
- Teuber SS, Rawley MJ, Yashida SH, et al. Anti-collagen antibodies are found in women with silicone breast implants. J Autoimmunity 1993; 6: 367–77
- Gabriel SE, Woods JE, O'Fallon WM, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336: 677–82
- Forsyth IA. Growth factors in mammary gland development. J Reprod Fertil 1989; 759–70
- De Leon DD, Bakker B., Wilson DM, et al. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding proteins in human breast cell lines. Biochem Biophys Res Commun 1988; 152: 398–405
- Clarke RB, Howell A., Anderson E. Type I insulinlike growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer 1997; 75: 251–7
- Cullen KJ, Yee D., Sly WS, et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990; 50: 48–53
- Ernst M., Heath JK, Rodan GA. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 1989; 125: 825–33
- Umayahara Y., Kawamori R., Watada H., et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 1994; 269: 16433–42
- Thorsen T., Lahooti H., Rasmussen M., et al. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol 1992; 41: 537–40
- Stewart AJ, Johnson MD, May FE, et al. Role of IGFs and the IGFR in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172–8
- Grodstein F., Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769–75